These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 10367565)

  • 1. Induction of P-glycoprotein functional activity and multidrug resistance by a soluble factor(s) produced by some mammalian cells.
    Eliseenkova AV; Ktitorova OV; Kakpakova ES; Sidorova TA; Stavrovskaya AA
    Membr Cell Biol; 1998; 12(4):469-79. PubMed ID: 10367565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated regulation of P-glycoprotein activity and cytochrome P-4501A induction in sublines of rat hepatoma McA RH7777 cells with different levels of colchicine resistance.
    Gujaeva EL; Kobliakov VA; Zabotina TN; Rybalkina EJ; Stravrovskaya AA
    Membr Cell Biol; 1998; 12(4):481-8. PubMed ID: 10367566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of regulatory proteins in L1210/VCR cells with multidrug resistance mediated by P-glycoprotein.
    Barancík M; Bohácová V; Zbýnovcová M; Breier A
    Gen Physiol Biophys; 1999 Mar; 18(1):45-56. PubMed ID: 10378120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.
    Kang CD; Ahn BK; Jeong CS; Kim KW; Lee HJ; Yoo SD; Chung BS; Kim SH
    Exp Cell Res; 2000 Apr; 256(1):300-7. PubMed ID: 10739677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-cycle-dependent turnover of P-glycoprotein in multidrug-resistant cells.
    Zhang W; Ling V
    J Cell Physiol; 2000 Jul; 184(1):17-26. PubMed ID: 10825230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
    Limtrakul P; Khantamat O; Pintha K
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
    Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
    Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A; Seth K; Kalra N; Shukla Y
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
    Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective modulation of P-glycoprotein-mediated drug resistance.
    Bebawy M; Morris MB; Roufogalis BD
    Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells.
    Lautier D; Canitrot Y; Salmon JM
    Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
    Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
    Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the multidrug-transporter P-glycoprotein by 3'-azido-3'-deoxythymidine (AZT) treatment in tumor cell lines.
    Signoretti C; Romagnoli G; Turriziani O; Antonelli G; Dianzani F; Cianfriglia M
    J Exp Clin Cancer Res; 1997 Mar; 16(1):29-32. PubMed ID: 9148857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein is overexpressed and functional in severely heat-shocked hepatoma cells.
    Hevér-Szabó A; Pirity M; Szathmári M; Venetianer A
    Anticancer Res; 1998; 18(4C):3045-8. PubMed ID: 9713507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
    Fong WF; Wan CK; Zhu GY; Chattopadhyay A; Dey S; Zhao Z; Shen XL
    Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine-resistance and enhancement of P-glycoprotein activity after co-cultivation of drug-sensitive cells with multidrug resistant variants.
    Eliseenkova AV; Kakpakova ES; Abdrjashitov RI; Stavrovskaya AA
    Cell Biol Int; 1995 Feb; 19(2):113-9. PubMed ID: 7742775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.